Search:

FDA Approval Headlines from PR Newswire


< Go Back

Safinamide Phase III Study Results Presented at 2013 MDS Meeting
RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants
Mentor Receives FDA Approval For MENTOR® MemoryShape™ Breast Implants
Cempra Provides Guidance on the Clinical Program Required for Regulatory Approval for Solithromycin for Community-Acquired Bacterial Pneumonia (CABP)
FDA Approves Amgen's XGEVA® (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
Orthopaedic Device Manufacturers Have No Choice: Unique Device Identification Necessitates Immediate Response
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinson's Disease and Movement Disorders
Magicool Plus® pioneering medical sprays now available on NHS Prescription and OTC
Abyrx,™ Inc. Receives FDA 510(k) Clearance for New Absorbable Hemostatic Bone Putty (AHBP™)
Approval Of Boston Scientific's Watchman Device Will Support Rapid Growth In The Global Heart Defect Closure Device Market
Dietary Supplement GMP Inspectional Readiness Virtual Conference
SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury
Cumberland Pharmaceuticals Reports FDA Approval For Updated Acetadote® Labeling
New Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults
The Leukemia & Lymphoma Society Applauds FDA's Approval of Lenalidomide for Patients with Relapsed or Refractory Mantle Cell Lymphoma
Actavis Confirms Generic Safyral® Patent Challenge
Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
Kinex Announces that the US FDA Allows their IND to Begin KX02 Clinical Trials
Cochlear Americas Receives FDA Approval for the First and Only Ear Level Accessory for Waterproof Hearing with Cochlear Implants
Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
Endo Pharmaceuticals Provides Regulatory Update On AVEED™ (Testosterone Undecanoate) Injection
AbbVie Announces Market Availability of New CREON® (pancrelipase) 36,000 Lipase-unit Capsules for Patients with Exocrine Pancreatic Insufficiency
Breathe Technologies Sleep System Receives FDA Clearance
Two new GSK oral oncology treatments, BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets, approved by FDA as single-agent therapies
Perrigo Announces FDA Final Approval For Generic Equivalent To Sanctura XR®
TWi Pharmaceuticals' Manufacturing Site for the Generic Version of Lidoderm(R) (Lidocane 5% patch) Passes US FDA cGMP Audit and Pre-Approval Inspection
Oramed CEO to Present at New York Biotechnology Association and The Israel Conference's Fast & Cool™ Session
Neuralstem's Cells Induce Improvement In Acute Spinal Cord Injury Rats, UCSD Study Shows
Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole
Sensus Healthcare Receives FDA Clearance to Treat Keloids with the SRT-100™
For breast cancer patients seeking a natural reconstruction, HydraSolve® liposuction from Andrew Technologies offers the first FDA-cleared option to provide your own fat for transfer
Press Statement on Behalf of the Singh Family (The Former Shareholders and Founders of Ranbaxy)
BioElectronics and Pulsed Shortwave Therapy Make Progress
Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
Bausch + Lomb Receives FDA Approval for the TRULIGN™ Toric Posterior Chamber Intraocular Lens
BioElectronics Presents FDA Reclassification Panel
Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening
Muscle Warfare a wholly owned subsidiary of Embark Holdings (EMBK) passes inspection by the FDA
New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy
FDA Sets 17 July 2013 For MOXDUO® Advisory Committee Meeting
Thoratec Announces FDA Approval Of HeartMate II® Pocket Controller™
Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
Mylan Launches Generic Tricor® Tablets
Syneron Introduces Enhancements to its Innovative Body Shaping Products
TaiGen Biotechnology Announces Submission of New Drug Application for Nemonoxacin in Taiwan and Mainland China
SIMPONI® (golimumab) Receives FDA Approval for Ulcerative Colitis
Mylan Launches Generic Zomig® Tablets
Bayer Receives U.S. FDA Approval for Xofigo® (radium Ra 223 dichloride) Injection as a New Treatment for Castration-Resistant Prostate Cancer with Bone Metastases
MiE's PET SCINTRON Receives FDA Approval

< Prev Next >
PR Newswire - United Business Media